Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 44996 [2024-11180]
Download as PDF
<![CDATA[
44996
Federal Register / Vol. 89, No. 100 / Wednesday, May 22, 2024 / Notices
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document (see DATES). Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest, attaching a
complete list of all such organizations,
and a list of all nominees along with
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for a particular device panel.
The interested organizations are not
bound by the list of nominees in
selecting a candidate. However, if no
individual is selected within 60 days,
the Commissioner will select the
nonvoting member to represent industry
interests.
IV. Application Procedure
Individuals may self-nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. Nomination
must include a current, complete
résumé or curriculum vitae for each
nominee including current business
address and telephone number, email
address if available, and a signed copy
of the Acknowledgement and Consent
form available at the FDA Advisory
Committee Membership Nomination
Portal (see ADDRESSES) within 30 days of
publication of this document (see
DATES). Nominations must also specify
the advisory panel for which the
nominee is recommended. Nominations
must also acknowledge that the
nominee is aware of the nomination
unless self-nominated. FDA will
forward all nominations to the
organizations expressing interest in
participating in the selection process for
the particular device panels listed in
table 1. (Persons who nominate
themselves as nonvoting industry
representatives will not participate in
the selection process.)
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees, and therefore encourages
nominations of appropriately qualified
candidates from these groups.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. 1001 et seq.), relating to advisory
committees.
Dated: May 16, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–11178 Filed 5–21–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2021–N–0403, FDA–
2023–N–4181, and FDA–2021–N–0584]
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB Control
No.
Title of collection
Food Additives; Food Contact Substances Notification System .............................................................................
Cattle Materials Prohibited From Use in Animal Food or Feed ..............................................................................
Standardized Reporting Forms for Federally Funded Public Health Projects and Agreements ............................
Dated: May 16, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–11180 Filed 5–21–24; 8:45 am]
Food and Drug Administration
[Docket No. FDA–2024–N–0970]
BILLING CODE 4164–01–P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Vaccines and Related Biological
Products Advisory Committee;
Amendment of Notice—Selection of
the 2024 to 2025 Formula for COVID–
19 Vaccines
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Sep<11>2014
17:06 May 21, 2024
Jkt 262001
PO 00000
Fmt 4703
4/30/2027
4/30/2027
4/30/2027
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of meeting of
the Vaccines and Related Biological
Products Advisory Committee. This
meeting was announced in the Federal
Register of March 4, 2024. The
amendment is being made to reflect a
change in the meeting date in the
SUMMARY and DATES portions of the
document from May 16, 2024, to June 5,
2024. There are no other changes.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Kathleen Hayes or Prabhakara Atreya,
Center for Biologics Evaluation and
Notice.
Frm 00041
0910–0495
0910–0627
0910–0909
Date approval
expires
Sfmt 4703
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 89, Number 100 (Wednesday, May 22, 2024)]
[Notices]
[Page 44996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11180]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2021-N-0403, FDA-2023-N-4181, and FDA-2021-N-0584]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-8867,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved By OMB
------------------------------------------------------------------------
OMB Control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Food Additives; Food Contact Substances 0910-0495 4/30/2027
Notification System....................
Cattle Materials Prohibited From Use in 0910-0627 4/30/2027
Animal Food or Feed....................
Standardized Reporting Forms for 0910-0909 4/30/2027
Federally Funded Public Health Projects
and Agreements.........................
------------------------------------------------------------------------
Dated: May 16, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-11180 Filed 5-21-24; 8:45 am]
BILLING CODE 4164-01-P
